# Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

> **NCT05608499** · PHASE3 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 15 (actual)

## Conditions studied

- Acne Keloidalis Nuchae
- AKN

## Interventions

- **DRUG:** Duobrii
- **DRUG:** Placebo
- **DRUG:** Bryhali

## Key facts

- **NCT ID:** NCT05608499
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-10-26
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Interim analysis did not show any significant differences between groups
- **Last updated:** 2025-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05608499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05608499, "Duobrii Treatment of Acne Keloidalis Nuchae (AKN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05608499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*